Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood–brain barrier device

Plant Biotechnology Journal

Volumn 15, Issue 10, 2017, Pages 1331-1339

  Phoolcharoen, Waranyoo ^a,b   Prehaud, Christophe ^c   van Dolleweerd, Craig J ^a   Both, Leonard ^a   da Costa, Anaelle ^c   Lafon, Monique ^c   Ma, Julian K C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c INSTITUT PASTEUR   (France)

Author keywords

antibody engineering; blood brain barrier; plant biotechnology; rabies virus; single chain antibody

Indexed keywords

GLYCOPROTEIN; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; NICOTINIC RECEPTOR; PEPTIDE FRAGMENT; PLANTIBODY; RABIES VIRUS GLYCOPROTEIN PEPTIDE; VIRAL PROTEIN;

BIOSYNTHESIS; BLOOD BRAIN BARRIER; CELL LINE; EVALUATION STUDY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; RABIES VIRUS; TOBACCO; TRANSGENIC PLANT;

ANTIBODIES, NEUTRALIZING; BLOOD-BRAIN BARRIER; CELL LINE; GLYCOPROTEINS; HUMANS; PEPTIDE FRAGMENTS; PLANTIBODIES; PLANTS, GENETICALLY MODIFIED; RABIES VIRUS; RECEPTORS, NICOTINIC; RECOMBINANT FUSION PROTEINS; TOBACCO; VIRAL PROTEINS;

EID: 85018586734     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12719     Document Type: Article

References (57)

1. Al-Shehri, A., Favretto, M.E., Ioannou, P.V., Romero, I.A., Couraud, P.O., Weksler, B.B., Parker, T.L. et al. (2015) Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy. Pharm. Res. 32, 1072–1083.
2. Alyautdin, R.N., Petrov, V.E., Langer, K., Berthold, A., Kharkevich, D.A. and Kreuter, J. (1997) Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm. Res. 14, 325–328.
3. Alyautdin, R.N., Tezikov, E.B., Ramge, P., Kharkevich, D.A., Begley, D.J. and Kreuter, J. (1998) Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J. Microencapsul. 15, 67–74.
4. Bird, R.E., Hardman, K.D., Jacobson, J.W., Johnson, S., Kaufman, B.M., Lee, S.M., Lee, T. et al. (1988) Single-chain antigen-binding proteins. Science, 242, 423–426.
5. Boado, R.J., Hui, E.K., Lu, J.Z., Zhou, Q.H. and Pardridge, W.M. (2010) Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein. J. Biotechnol. 146, 84–91.
6. Both, L., van Dolleweerd, C., Wright, E., Banyard, A.C., Bulmer-Thomas, B., Selden, D., Altmann, F. et al. (2013) Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. FASEB J. 27, 2055–2065.
7. Bracci, L., Antoni, G., Cusi, M.G., Lozzi, L., Niccolai, N., Petreni, S., Rustici, M. et al. (1988) Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor. Mol. Immunol. 25, 881–888.
8. Burrage, T.G., Tignor, G.H. and Smith, A.L. (1985) Rabies virus binding at neuromuscular junctions. Virus Res. 2, 273–289.
9. Chopy, D., Detje, C.N., Lafage, M., Kalinke, U. and Lafon, M. (2011) The type I interferon response bridles rabies virus infection and reduces pathogenicity. J. Neurovirol. 17, 353–367.
10. Donnelly-Roberts, D.L. and Lentz, T.L. (1989) Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor. Pept. Res. 2, 221–226.
11. Eigenmann, D.E., Xue, G., Kim, K.S., Moses, A.V., Hamburger, M. and Oufir, M. (2013) Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS, 10, 33.
12. Fooks, A.R., Banyard, A.C., Horton, D.L., Johnson, N., McElhinney, L.M. and Jackson, A.C. (2014) Current status of rabies and prospects for elimination. Lancet, 384, 1389–1399.
13. Friden, P.M., Walus, L.R., Musso, G.F., Taylor, M.A., Malfroy, B. and Starzyk, R.M. (1991) Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl Acad. Sci. USA, 88, 4771–4775.
14. Fu, A., Wang, Y., Zhan, L. and Zhou, R. (2012) Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide. Pharm. Res. 29, 1562–1569.
15. Greene, L.A. and Tischler, A.S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA, 73, 2424–2428.
16. Gulyaev, A.E., Gelperina, S.E., Skidan, I.N., Antropov, A.S., Kivman, G.Y. and Kreuter, J. (1999) Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm. Res. 16, 1564–1569.
17. Hefferon, K. (2013) Plant-derived pharmaceuticals for the developing world. Biotechnol. J. 8, 1193–1202.
18. van der Helm, M.W., van der Meer, A.D., Eijkel, J.C., van den Berg, A. and Segerink, L.I. (2016) Microfluidic organ-on-chip technology for blood-brain barrier research. Tissue Barriers. 4, e1142493.
19. Hemachudha, T., Laothamatas, J. and Rupprecht, C.E. (2002) Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol. 1, 101–109.
20. Hwang do, W., Son, S., Jang, J., Youn, H., Lee, S., Lee, D., Lee, Y.S. et al. (2011) A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials, 32, 4968–4975.
21. Jekic, M. (1979) Pathogenetic mechanisms of septic states in war injuries. Acta Chir. Iugosl. 26, 71–72.
22. Kim, J.Y., Choi, W.I., Kim, Y.H. and Tae, G. (2013) Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials, 34, 1170–1178.
23. Kohli, N., Westerveld, D.R., Ayache, A.C., Verma, A., Shil, P., Prasad, T., Zhu, P. et al. (2014) Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers. Mol. Ther. 22, 535–546.
24. Kumar, P., Wu, H., McBride, J.L., Jung, K.E., Kim, M.H., Davidson, B.L., Lee, S.K. et al. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature, 448, 39–43.
25. Kwon, K.C. and Daniell, H. (2016) Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells. Mol. Ther. 24, 1342–1350.
26. Lentz, T.L. (1990) Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J. Mol. Recognit. 3, 82–88.
27. Lentz, T.L. (1991) Structure-function relationships of curaremimetic neurotoxin loop 2 and of a structurally similar segment of rabies virus glycoprotein in their interaction with the nicotinic acetylcholine receptor. Biochemistry 30, 10949–10957.
28. Lentz, T.L., Burrage, T.G., Smith, A.L., Crick, J. and Tignor, G.H. (1982) Is the acetylcholine receptor a rabies virus receptor? Science, 215, 182–184.
29. Lentz, T.L., Wilson, P.T., Hawrot, E. and Speicher, D.W. (1984) Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science, 226, 847–848.
30. Lentz, T.L., Hawrot, E. and Wilson, P.T. (1987) Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor. Proteins, 2, 298–307.
31. Lentz, T.L., Hawrot, E., Donnelly-Roberts, D. and Wilson, P.T. (1988) Synthetic peptides in the study of the interaction of rabies virus and the acetylcholine receptor. Adv. Biochem. Psychopharmacol. 44, 57–71.
32. Lewis, P., Fu, Y. and Lentz, T.L. (2000) Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve, 23, 720–730.
33. Lim, K.J., Sung, B.H., Shin, J.R., Lee, Y.W., Kim, D.J., Yang, K.S. and Kim, S.C. (2013) A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. PLoS ONE, 8, e66084.
34. Liu, Y., Huang, R., Han, L., Ke, W., Shao, K., Ye, L., Lou, J. et al. (2009) Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials, 30, 4195–4202.
35. Louie, R.E., Dobkin, M.B., Meyer, P., Chin, B., Roby, R.E., Hammar, A.H. and Cabasso, V.J. (1975) Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test (RFFIT). J. Biol.Stand. 3, 365–373.
36. Ma, S., Liu, X., Xu, Q. and Zhang, X. (2014) Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood-brain barrier cell model. Life Sci. 114, 93–101.
37. Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I.A., Weksler, B., Couraud, P.O. and Antimisiaris, S.G. (2011) Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Eur. J. Pharm. Biopharm. 77, 265–274.
38. McQuarrie, C., Salvaterra, P.M., De Blas, A., Routes, J. and Mahler, H.R. (1976) Studies on nicotinic acetylcholine receptors in mammalian brain. Preliminary characterization of membrane-bound alpha-bungarotoxin receptors in rat cerebral cortex. J. Biol. Chem. 251, 6335–6339.
39. Megret, F., Prehaud, C., Lafage, M., Batejat, C., Escriou, N., Lay, S., Thoulouze, M.I. et al. (2005) Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis. Vaccine, 23, 5342–5350.
40. Muller, T., Dietzschold, B., Ertl, H., Fooks, A.R., Freuling, C., Fehlner-Gardiner, C., Kliemt, J. et al. (2009) Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl. Trop Dis. 3, e542.
41. Pardridge, W.M. (2010) Biopharmaceutical drug targeting to the brain. J. Drug Target. 18, 157–167.
42. Pardridge, W.M. (2015) Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody. Expert. Opin. Drug. Deliv. 12, 207–222.
43. Pardridge, W.M., Eisenberg, J. and Yang, J. (1985) Human blood-brain barrier insulin receptor. J. Neurochem. 44, 1771–1778.
44. Peyret, H. and Lomonossoff, G.P. (2013) The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants. Plant Mol. Biol. 83, 51–58.
45. Rosales-Mendoza, S. (2015) Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies. Mol. Biotechnol. 57, 869–879.
46. Roy, S., Tyagi, A., Tiwari, S., Singh, A., Sawant, S.V., Singh, P.K. and Tuli, R. (2010) Rabies glycoprotein fused with B subunit of cholera toxin expressed in tobacco plants folds into biologically active pentameric proteins. Protein Expr. Purif. 70, 184–190.
47. Rustici, M., Santucci, A., Lozzi, L., Petreni, S., Spreafico, A., Neri, P., Bracci, L. et al. (1989) A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor. J. Mol. Recognit. 2, 51–55.
48. Sainsbury, F., Thuenemann, E.C. and Lomonossoff, G.P. (2009) pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol. J. 7, 682–693.
49. Schwarze, S.R., Ho, A., Vocero-Akbani, A. and Dowdy, S.F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 285, 1569–1572.
50. Shahid, N. and Daniell, H. (2016) Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotechnol. J. 14, 2079–2099.
51. Shantavasinkul, P. and Wilde, H. (2011) Postexposure prophylaxis for rabies in resource-limited/poor countries. Adv. Virus Res. 79, 291–307.
52. Siflinger-Birnboim, A., Del Vecchio, P.J., Cooper, J.A., Blumenstock, F.A., Shepard, J.M. and Malik, A.B. (1987) Molecular sieving characteristics of the cultured endothelial monolayer. J. Cell. Physiol. 132, 111–117.
53. Thoulouze, M.I., Lafage, M., Montano-Hirose, J.A. and Lafon, M. (1997) Rabies virus infects mouse and human lymphocytes and induces apoptosis. J. Virol. 71, 7372–7380.
54. Tzartos, S.J. and Changeux, J.P. (1983) High affinity binding of alpha-bungarotoxin to the purified alpha-subunit and to its 27,000-dalton proteolytic peptide from Torpedo marmorata acetylcholine receptor. Requirement for sodium dodecyl sulfate. EMBO J. 2, 381–387.
55. Uwanyiligira, M., Landry, P., Genton, B. and de Valliere, S. (2012) Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations. Clin. Infect. Dis. 55, 201–205.
56. Xiang, L., Zhou, R., Fu, A., Xu, X., Huang, Y. and Hu, C. (2011) Targeted delivery of large fusion protein into hippocampal neurons by systemic administration. J. Drug Target. 19, 632–636.
57. Yamauchi, J.G., Nemecz, A., Nguyen, Q.T., Muller, A., Schroeder, L.F., Talley, T.T., Lindstrom, J. et al. (2011) Characterizing ligand-gated ion channel receptors with genetically encoded Ca2 + + sensors. PLoS ONE, 6, e16519.